drugset / Trial / NCT02046525

Autologous Fecal Therapy

NCT02046525 ↗

Phase 2 Completed 10 enrolled Washington University School of Medicine
RandomizedParallel-groupSingle-blindPrevention

Summary

Ten healthy volunteers will be recruited to receive either an autologous stool transplant or a saline enema to determine if autologous fecal microbiota therapy will be able to rapidly, and safely, restore a patient's fecal microbiome after antimicrobial exposure.

Timeline

Start
2014-03
Primary completion
2018-12
Completion
2018-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Autologous fecal microbiota therapy Other / unclassified — Rectal